ThomasKMundorfMD

PubMed

• 5 citations
  Effects of Netarsudil on the Corneal Endothelium: Three-Month Findings from a Phase 3 Trial.
  Thomas Mundorf, Francis S. Mah, Huan Sheng, Theresa Heah> ;Ophthalmology. Glaucoma. 2020 Apr 29
• 31 citations
  Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomis...
  Douglas G. Day, Thomas R Walters, Gail F. Schwartz, Thomas K Mundorf, Charlie Liu, Rhett M. Schiffman, Marina Bejanian> ;The British Journal of Ophthalmology. 2013 Aug 1
• 76 citations
  A phase 2 randomized, double-masked, placebo-controlled study of a novel integrin antagonist (SAR 1118) for the treatment of dry eye.
  Charles P. Semba, Gail Torkildsen, John Lonsdale, Eugene B McLaurin, Joel A. Geffin, Thomas K. Mundorf, Kathryn S. Kennedy, George W Ousler> ;American Journal of Ophthalmology. 2012 Jun 1
• 3 citations
  Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/...
  Sriram Sonty, Thomas K. Mundorf, Jeanette A. Stewart, William C. Stewart> ;Clinical Therapeutics. 2009 Oct 1
• 35 citations
  A patient preference comparison of Azarga™ (brinzolamide/timolol fixed combination) vs Cosopt ® (dorzolamide/timolol fixed combination) in patients with open-angle gla...
  Thomas K Mundorf, Steven H Rauchman, Robert D Williams, Ricardo Notivol> ;Clinical Ophthalmology. 2008 Sep 12
• 9 citations
  Ocular hypotensive efficacy of brimonidine 0.15% as adjunctive therapy with latanoprost 0.005% in patients with open-angle glaucoma or ocular hypertension
  Thomas Mundorf, Robert J. Noecker, Melissa L. Earl> ;Advances in Therapy. 2007 Mar 1
• 16 citations
  Comparing bimatoprost and travoprost in black Americans
  Robert J. Noecker, Melissa L. Earl, Thomas Mundorf, Steven M Silverstein, Michael P Phillips> ;Current Medical Research and Opinion. 2006 Oct 4
• 3 citations
  Timolol LA: a double-masked, active-controlled, randomized, crossover, comfort, ocular safety, and systemic bioavailability study in healthy volunteers.
  Thomas K. Mundorf, Takahiro Ogawa, Noritsugu Inui, Hiroaki Naka, Gary D. Novack, R. Stephens Crockett> ;Current Medical Research and Opinion. 2005 Feb 23
• 5 citations
  Efficacy of Bimatoprost 0.03 percent in untreated glaucoma and ocular hypertension patients: Results from a large community-based clinical trial
  Richard Quinones, Todd Severin, Thomas Mundorf> ;Journal of Ocular Pharmacology and Therapeutics. 2004 Apr 1
• 19 citations
  A 12-month, multicenter, randomized, double-masked, parallel-group comparison of timolol-LA once daily and timolol maleate ophthalmic solution twice daily in the treat...
  Thomas K. Mundorf, Takahiro Ogawa, Hiroaki Naka, Gary D. Novack, R. Stephens Crockett> ;Clinical Therapeutics. 2004 Apr 1
• 23 citations
  Efficacy and safety of ketotifen fumarate 0.025% in the conjunctival antigen challenge model of ocular allergic conjunctivitis
  Jack V. Greiner, Thomas K. Mundorf, Harvey Dubiner, John Lonsdale, Richard Casey, Leonard M. Parver, Barry Kapik, Naveed Shams, Mark B. Abelson> ;American Journal of Ophthalmology. 2003 Dec 1
• 24 citations
  Evaluation of the comfort of Alphagan P compared with Alphagan in irritated eyes.
  Thomas K. Mundorf, K.A. Wilcox, George W Ousler, Donna Welch, Mark B. Abelson> ;Advances in Therapy. 2003 Nov 1
• 29 citations
  A 3-month comparison of efficacy and safety of brimonidine-purite 0.15% and brimonidine 0.2% in patients with glaucoma or ocular hypertension.
  Tom Mundorf, Robert Williams, Scott M. Whitcup, Carlos Felix, Amy L. Batoosingh> ;Journal of Ocular Pharmacology and Therapeutics. 2003 Feb 1
• 18 citations
  Pemirolast Potassium 0.1% Ophthalmic Solution is an Effective Treatment for Allergic Conjunctivitis: A Pooled Analysis of Two Prospective, Randomized, Double-masked, P...
  Mark B. Abelson, Gregg J. Berdy, Thomas K. Mundorf, Lawrence D. Amdahl, Adrienne L. Graves> ;Journal of Ocular Pharmacology and Therapeutics. 2002 Oct 1
• 11 citations
  Best practice treatment algorithm for primary open-angle glaucoma: implications for U.S. ophthalmology practice.
  Janet B. Serle, Louis B. Cantor, Ron Gross, Jay Katz, Thomas Mundorf, Robert Noecker, Todd Severin, Steve Simmons, John G Walt, J Casciano, Stacy J. Evans, John Doyle> ;Managed Care Interface. 2002 Jul 1
• 28 citations
  Effects of carteolol and timolol on plasma lipid profiles in older women with ocular hypertension or primary open-angle glaucoma.
  William C. Stewart, Harvey Dubiner, Thomas K. Mundorf, Robert A. Laibovitz, Kenneth N Sall, L. J. Katz, Kuldev Singh, David G Shulman, Les I. Siegel, Alison C. Hudgins...> ;American Journal of Ophthalmology. 1999 Feb 1
• 29 citations
  The Efficacy and Safety of Diclofenac 0.1% Versus Prednisolone Acetate 1% Following Trabeculectomy With Adjunctive Mitomycin-C
  Alexander R. Kent, Harvey Dubiner, Roy Whitaker, Thomas K. Mundorf, Jeanette A. Stewart, Elin A. Cate, William C. Stewart> ;Ophthalmic Surgery and Lasers. 1998 Jul 1
• 33 citations
  The safety and efficacy of switching timolol maleate 0.5% solution to timolol hemihydrate 0.5% solution given twice daily.
  Thomas K. Mundorf, Elin A. Cate, Cheryl S. Sine, Donna W. Otero, Jeanette A. Stewart, William C. Stewart> ;Journal of Ocular Pharmacology and Therapeutics. 1998 Apr 1
• 11 citations
  Timolol Hemihydrate vs Timolol Maleate to Treat Ocular Hypertension and Open-Angle Glaucoma
  Harvey Dubiner, Richard A. Hill, Herbert E. Kaufman, Edwin U. Keates, Thom J. Zimmerman, Alan I. Mandell, Thomas K. Mundorf, Robert L. Bahr, Louis W. Schwartz, Anne W....> ;American Journal of Ophthalmology. 1996 May 1
• 36 citations
  The spectrum of cavitary optic disc anomalies in a family.
  M. Madison Slusher, R. Grey Weaver, Craig M. Greven, Thomas K. Mundorf, L. Frank Cashwell> ;Ophthalmology. 1989 Mar 1
• 4 citations
  Tolerability of timolol and betaxolol in patients with chronic open-angle glaucoma.
  Kendall K, Thomas K. Mundorf, Nardin G, Zimmerman Tj, Hesse R, Lavin P> ;Clinical Therapeutics. 1987 Jan 1
• 14 citations
  Automated perimetry, tonometry, and questionnaire in glaucoma screening.
  Thomas K. Mundorf, T. J. Zimmerman, George F. Nardin, Kenyon S. Kendall> ;American Journal of Ophthalmology. 1989 Nov 1
• 563 citations
  Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group.
  Kenneth N Sall, Onex Dara Stevenson, Thomas K. Mundorf, Brenda L. Reis> ;Ophthalmology. 2000 Apr 1
• Topical apraclonidine hydrochloride in eyes with poorly controlled glaucoma. The Apraclonidine Maximum Tolerated Medical Therapy Study Group.
  Robin, A. L., Ritch, R., Shin, D., Smythe, B., Mundorf, T., Lehmann, R. P.> ;Trans Am Ophthalmol Soc. 1995
• Short-term efficacy of apraclonidine hydrochloride added to maximum-tolerated medical therapy for glaucoma. Apraclonidine Maximum-Tolerated Medical Therapy Study Group.
  Robin, A. L., Ritch, R., Shin, D. H., Smythe, B., Mundorf, T., Lehmann, R. P.> ;Am J Ophthalmol. 1995 Oct
• Join now to see all